Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gold

Showing results (521-530 of 596) with videos related to

Pageof 60
Sort By:
World Neurosurgery|May 23, 2022
Spinal Meningioma in Adults: Imaging Characteristics, Surgical Outcomes, and Risk Factors for RecurrenceBrian J Park, Mark C Dougherty, Jennifer Noeller, et al.
F1000Research|November 25, 2024
Using the R Package, <i>nsink,</i> to assess landscape N removal in coastal catchmentsDorothy Q Kellogg, Jeffrey W Hollister, Chester L Arnold, et al.
Cancer Chemotherapy and Pharmacology|October 18, 2014
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancerH S Hochster, N Uboha, W Messersmith, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2018
Pharmacokinetics and pharmacodynamics of the novel monobactam LYS228 in a neutropenic murine thigh model of infectionE J Growcott, T A Cariaga, L Morris, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2018
Pharmacokinetics and pharmacodynamics of the novel monobactam LYS228 in a neutropenic murine thigh model of infectionE J Growcott, T A Cariaga, L Morris, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2012
Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414)Michael B Tomblyn, Bryan H Goldman, Charles R Thomas, et al.
AIDS (London, England)|March 9, 2000
B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDSA E Grulich, X Wan, M G Law, et al.
Reproductive Biomedicine Online|January 31, 2012
Progesterone stimulates expression of follistatin splice variants Fst288 and Fst315 in the mouse uterusR G Craythorn, W R Winnall, F Lederman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2003
Essential role for RGS9 in opiate actionVenetia Zachariou, Dan Georgescu, Nick Sanchez, et al.
Cancer Immunology Research|February 19, 2022
Overproduction of IFNγ by Cbl-b-Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor ImmunitySeongJun Han, Zhe Qi Liu, Douglas C Chung, et al.
Pageof 60

Showing results (521-530 of 596) with videos related to

Sort By:
Pageof 60
World Neurosurgery|May 23, 2022
Spinal Meningioma in Adults: Imaging Characteristics, Surgical Outcomes, and Risk Factors for RecurrenceBrian J Park, Mark C Dougherty, Jennifer Noeller, et al.
F1000Research|November 25, 2024
Using the R Package, <i>nsink,</i> to assess landscape N removal in coastal catchmentsDorothy Q Kellogg, Jeffrey W Hollister, Chester L Arnold, et al.
Cancer Chemotherapy and Pharmacology|October 18, 2014
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancerH S Hochster, N Uboha, W Messersmith, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2018
Pharmacokinetics and pharmacodynamics of the novel monobactam LYS228 in a neutropenic murine thigh model of infectionE J Growcott, T A Cariaga, L Morris, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2018
Pharmacokinetics and pharmacodynamics of the novel monobactam LYS228 in a neutropenic murine thigh model of infectionE J Growcott, T A Cariaga, L Morris, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2012
Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414)Michael B Tomblyn, Bryan H Goldman, Charles R Thomas, et al.
AIDS (London, England)|March 9, 2000
B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDSA E Grulich, X Wan, M G Law, et al.
Reproductive Biomedicine Online|January 31, 2012
Progesterone stimulates expression of follistatin splice variants Fst288 and Fst315 in the mouse uterusR G Craythorn, W R Winnall, F Lederman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2003
Essential role for RGS9 in opiate actionVenetia Zachariou, Dan Georgescu, Nick Sanchez, et al.
Cancer Immunology Research|February 19, 2022
Overproduction of IFNγ by Cbl-b-Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor ImmunitySeongJun Han, Zhe Qi Liu, Douglas C Chung, et al.
Pageof 60